Janus Henderson Group PLC Alkermes Plc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in Alkermes Plc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 72,973 shares of ALKS stock, worth $2.13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,973

Previous 72,973 -0.0%

Holding current value

$2.13 Million

Previous $1.76 Million 16.15%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$23.21 - $27.24 $18,823 - $22,091	-811 Reduced 1.1%	72,973 $1.76 Million
Q1 2024 May 15, 2024	SELL	$26.4 - $32.56 $1,056 - $1,302	-40 Reduced 0.05%	73,784 $2 Million
Q4 2023 Feb 14, 2024	SELL	$23.37 - $28.68 $2,991 - $3,671	-128 Reduced 0.17%	73,824 $2.05 Million
Q3 2023 Nov 14, 2023	BUY	$27.17 - $31.97 $271 - $319	10 Added 0.01%	73,952 $2.07 Million
Q2 2023 Aug 14, 2023	SELL	$28.34 - $33.63 $2,267 - $2,690	-80 Reduced 0.11%	73,942 $2.31 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $995,695 - $1.14 Million	39,340 Added 113.43%	74,022 $2.09 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $125,058 - $149,568	5,700 Added 19.67%	34,682 $906,000
Q3 2022 Nov 14, 2022	BUY	$22.0 - $31.87 $1,474 - $2,135	67 Added 0.23%	28,982 $648,000
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $90,552 - $104,752	-3,430 Reduced 10.6%	28,915 $862,000
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $184 - $223	8 Added 0.02%	32,345 $851,000
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $349,188 - $521,749	16,264 Added 101.19%	32,337 $753,000
Q3 2021 Nov 16, 2021	BUY	$23.37 - $32.13 $375,626 - $516,425	16,073 New	16,073 $496,000
Q4 2019 Feb 18, 2020	SELL	$17.29 - $21.74 $593,548 - $746,312	-34,329 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$19.51 - $24.28 $1.66 Million - $2.07 Million	-85,258 Reduced 71.29%	34,329 $669,000
Q2 2019 Jul 31, 2019	SELL	$21.47 - $37.33 $40.6 Million - $70.5 Million	-1,889,441 Reduced 94.05%	119,587 $2.7 Million
Q1 2019 Apr 30, 2019	SELL	$28.4 - $36.49 $176,364 - $226,602	-6,210 Reduced 0.31%	2,009,028 $73.3 Million
Q4 2018 Feb 06, 2019	SELL	$27.94 - $44.61 $109,440 - $174,737	-3,917 Reduced 0.19%	2,015,238 $59.5 Million
Q3 2018 Nov 09, 2018	SELL	$38.6 - $46.12 $717,265 - $857,001	-18,582 Reduced 0.91%	2,019,155 $85.7 Million
Q2 2018 Aug 10, 2018	BUY	$40.56 - $51.36 $761,757 - $964,592	18,781 Added 0.93%	2,037,737 $83.9 Million
Q1 2018 May 14, 2018	SELL	$53.61 - $67.26 $41.3 Million - $51.8 Million	-770,864 Reduced 27.63%	2,018,956 $117 Million
Q4 2017 Feb 09, 2018	BUY	$47.69 - $55.39 $6.67 Million - $7.74 Million	139,814 Added 5.28%	2,789,820 $153 Million
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $15.7 Million - $17.4 Million	319,014 Added 13.69%	2,650,006 $0
Q2 2017 Aug 17, 2017	BUY	N/A	2,330,992	2,330,992 $135 Million

Others Institutions Holding ALKS

# of Institutions

352

Shares Held

179M

Call Options Held

209K

Put Options Held

89.4K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.8B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Alkermes Plc. Transaction History